F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate

Fluorine-18 prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography scan is widely used for restaging of prostate cancer. We present a case where false-positive PSMA uptake was seen in metachronous carcinoma breast during restaging workup of carcinoma prostate.

Detalles Bibliográficos
Autores principales: Zade, Anand, Shetty, Shishir, Ambekar, Asawari, Karpe, Makarand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Interesting Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855249/
https://www.ncbi.nlm.nih.gov/pubmed/36686311
http://dx.doi.org/10.4103/ijnm.ijnm_127_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855249/
https://www.ncbi.nlm.nih.gov/pubmed/36686311
http://dx.doi.org/10.4103/ijnm.ijnm_127_21

Ejemplares similares